-
1
-
-
79959990099
-
Personalized medicine: New genomics, old lessons
-
K. Offit Personalized medicine: new genomics, old lessons Hum Genet 130 2001 3 14
-
(2001)
Hum Genet
, vol.130
, pp. 3-14
-
-
Offit, K.1
-
2
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshirani, R.3
-
3
-
-
27644507366
-
Fragile X syndrome: Diagnostic and carrier testing
-
S. Sherman, B.A. Pletcher, and D.A. Driscoll Fragile X syndrome: diagnostic and carrier testing Genet Med 7 2005 584 587
-
(2005)
Genet Med
, vol.7
, pp. 584-587
-
-
Sherman, S.1
Pletcher, B.A.2
Driscoll, D.A.3
-
4
-
-
26844503270
-
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
-
M.J. Piccart-Gebhart, M. Procter, and B. Leyland-Jones Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 2005 1659 1672
-
(2005)
N Engl J Med
, vol.353
, pp. 1659-1672
-
-
Piccart-Gebhart, M.J.1
Procter, M.2
Leyland-Jones, B.3
-
5
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
-
E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
-
(2005)
N Engl J Med
, vol.353
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
-
6
-
-
69249219296
-
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
-
(2009)
JAMA
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
O'Connell, J.R.2
Bliden, K.P.3
-
7
-
-
15944383403
-
Gene-environment interactions in human diseases
-
D.J. Hunter Gene-environment interactions in human diseases Nat Rev Genet 6 2005 287 298
-
(2005)
Nat Rev Genet
, vol.6
, pp. 287-298
-
-
Hunter, D.J.1
-
8
-
-
84868293626
-
Gene/environment interaction in atherosclerosis: An example of clinical medicine as seen from the evolutionary perspective
-
G. Mertens Gene/environment interaction in atherosclerosis: an example of clinical medicine as seen from the evolutionary perspective Int J Hypertens 2010 654078
-
(2010)
Int J Hypertens
, pp. 654078
-
-
Mertens, G.1
-
9
-
-
77954267769
-
Personalized smoking cessation: Interactions between nicotine dose, dependence and quit-success genotype score
-
J.E. Rose, F.M. Behm, and T. Drgon Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score Mol Med 16 2010 247 253
-
(2010)
Mol Med
, vol.16
, pp. 247-253
-
-
Rose, J.E.1
Behm, F.M.2
Drgon, T.3
-
10
-
-
84861883171
-
Genetic mapping of habitual substance use, obesity-related traits, responses to mental and physical stress, and heart rate and blood pressure measurements reveals shared genes that are overrepresented in the neural synapse
-
[Epub ahead of print, February 2nd]
-
Nikpay M, Seda O, Tremblay J, et al. Genetic mapping of habitual substance use, obesity-related traits, responses to mental and physical stress, and heart rate and blood pressure measurements reveals shared genes that are overrepresented in the neural synapse. Hypertens.Res., http://dx.doi.org/10. 1038/hr.2011.233. [Epub ahead of print, February 2nd, 2012].
-
(2012)
Hypertens.Res.
-
-
Nikpay, M.1
Seda, O.2
Tremblay, J.3
-
11
-
-
77955620636
-
Personalized medicine in oncology: Tailoring the right drug to the right patient
-
Y. Jiang, and M. Wang Personalized medicine in oncology: tailoring the right drug to the right patient Biomark Med 4 2010 523 533
-
(2010)
Biomark Med
, vol.4
, pp. 523-533
-
-
Jiang, Y.1
Wang, M.2
-
12
-
-
49949104757
-
SLCO1B1 variants and statin-induced myopathy - A genomewide study
-
E. Link, S. Parish, and J. Armitage SLCO1B1 variants and statin-induced myopathy - a genomewide study N Engl J Med 359 2008 789 799
-
(2008)
N Engl J Med
, vol.359
, pp. 789-799
-
-
Link, E.1
Parish, S.2
Armitage, J.3
-
13
-
-
77952822074
-
PheWAS: Demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations
-
J.C. Denny, M.D. Ritchie, and M.A. Basford PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations Bioinformatics 26 2010 1205 1210
-
(2010)
Bioinformatics
, vol.26
, pp. 1205-1210
-
-
Denny, J.C.1
Ritchie, M.D.2
Basford, M.A.3
-
14
-
-
79958154438
-
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery
-
S.A. Pendergrass, K. Brown-Gentry, and S.M. Dudek The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery Genet Epidemiol 35 2011 410 422
-
(2011)
Genet Epidemiol
, vol.35
, pp. 410-422
-
-
Pendergrass, S.A.1
Brown-Gentry, K.2
Dudek, S.M.3
-
15
-
-
84870556394
-
The emergence of participatory medicine
-
3rd edition, 16
-
Snyderman R: The emergence of participatory medicine. Personalized medicine coalition 3rd edition. 2011; 16-17.
-
(2011)
Personalized Medicine Coalition
, pp. 16
-
-
Snyderman, R.1
-
16
-
-
80755125639
-
Genomic information as a behavioral health intervention: Can it work?
-
C.S. Bloss, L. Madlensky, and N.J. Schork Genomic information as a behavioral health intervention: can it work? Per Med 8 2011 659 667
-
(2011)
Per Med
, vol.8
, pp. 659-667
-
-
Bloss, C.S.1
Madlensky, L.2
Schork, N.J.3
|